Owen R Vaughan1, Fredrick J Rosario2, Theresa L Powell2,3, Thomas Jansson2. 1. Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. owen.vaughan@ucdenver.edu. 2. Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. 3. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Abstract
BACKGROUND/ OBJECTIVES: Adiponectin concentrations are low in obese pregnant women. Restoring normal adiponectin concentrations by infusion in obese pregnant mice prevents placental dysfunction, foetal overgrowth and metabolic syndrome in the offspring. We hypothesised that normalising maternal adiponectin in obese late pregnant dams prevents cardiac dysfunction in the adult offspring. SUBJECTS/ METHODS: Pregnant female mice with diet-induced obesity were infused with adiponectin (0.62 μg g-1 day-1, n = 24) or saline (n = 22) over days 14.5-18.5 of pregnancy (term = day 19.5). Control dams ate standard chow and received saline (n = 22). Offspring were studied at 3 and 6 months of age. RESULTS: Maternal obesity impaired ventricular diastolic function, increased cardiomyocyte cross-sectional area and upregulated cardiac brain natriuretic peptide (Nppb) and α-skeletal actin (Acta1) gene expression in adult male offspring, compared to control offspring. In adult female offspring, maternal obesity increased Nppb expression, decreased end-diastolic volume and caused age-dependent diastolic dysfunction but not cardiomyocyte hypertrophy. Maternal obesity also activated cardiac Akt and mechanistic target of rapamycin (mTOR) signalling in male, but not in female, offspring and inhibited cardiac extracellular signal-regulated kinase 1/2 (ERK1/2) in both sexes. Normalising maternal circulating adiponectin concentrations by infusing obese dams with adiponectin prevented offspring diastolic dysfunction and ventricular dilation and normalised cardiac Akt-mTOR signalling irrespective of sex. Maternal adiponectin infusion also reduced cardiac Nppb expression and increased ERK1/2 signalling in offspring of obese dams. Adiponectin infusion did not prevent cardiomyocyte hypertrophy but reduced ventricular wall thickness in male offspring and increased collagen content in female offspring of obese dams, compared to controls. CONCLUSIONS: Low maternal adiponectin levels in obese mice in late pregnancy are mechanistically linked to in utero programming of cardiac dysfunction in their offspring. Interventions enhancing endogenous adiponectin secretion or signalling in obese pregnant women could prevent the development of cardiac dysfunction in their children.
BACKGROUND/ OBJECTIVES:Adiponectin concentrations are low in obese pregnant women. Restoring normal adiponectin concentrations by infusion in obese pregnant mice prevents placental dysfunction, foetal overgrowth and metabolic syndrome in the offspring. We hypothesised that normalising maternal adiponectinin obese late pregnant dams prevents cardiac dysfunction in the adult offspring. SUBJECTS/ METHODS: Pregnant female mice with diet-induced obesity were infused with adiponectin (0.62 μg g-1 day-1, n = 24) or saline (n = 22) over days 14.5-18.5 of pregnancy (term = day 19.5). Control dams ate standard chow and received saline (n = 22). Offspring were studied at 3 and 6 months of age. RESULTS:Maternal obesity impaired ventricular diastolic function, increased cardiomyocyte cross-sectional area and upregulated cardiac brain natriuretic peptide (Nppb) and α-skeletal actin (Acta1) gene expression in adult male offspring, compared to control offspring. In adult female offspring, maternal obesity increased Nppb expression, decreased end-diastolic volume and caused age-dependent diastolic dysfunction but not cardiomyocyte hypertrophy. Maternal obesity also activated cardiac Akt and mechanistic target of rapamycin (mTOR) signalling in male, but not in female, offspring and inhibited cardiac extracellular signal-regulated kinase 1/2 (ERK1/2) in both sexes. Normalising maternal circulating adiponectin concentrations by infusing obese dams with adiponectin prevented offspring diastolic dysfunction and ventricular dilation and normalised cardiac Akt-mTOR signalling irrespective of sex. Maternal adiponectin infusion also reduced cardiac Nppb expression and increased ERK1/2 signalling in offspring of obese dams. Adiponectin infusion did not prevent cardiomyocyte hypertrophy but reduced ventricular wall thickness in male offspring and increased collagen content in female offspring of obese dams, compared to controls. CONCLUSIONS: Low maternal adiponectin levels in obesemice in late pregnancy are mechanistically linked to in utero programming of cardiac dysfunction in their offspring. Interventions enhancing endogenous adiponectin secretion or signalling in obese pregnant women could prevent the development of cardiac dysfunction in their children.
Authors: Katherine M Flegal; Deanna Kruszon-Moran; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden Journal: JAMA Date: 2016-06-07 Impact factor: 56.272
Authors: Jingying Wang; Heng Ma; Chao Tong; Hanying Zhang; Gavin B Lawlis; Yuanda Li; Mengwei Zang; Jun Ren; Mark J Nijland; Stephen P Ford; Peter W Nathanielsz; Ji Li Journal: FASEB J Date: 2010-01-28 Impact factor: 5.191
Authors: Xiujuan Fan; Subat Turdi; Stephen P Ford; Yinan Hua; Mark J Nijland; Meijun Zhu; Peter W Nathanielsz; Jun Ren Journal: J Nutr Biochem Date: 2010-02-25 Impact factor: 6.048
Authors: Kennedy S Mdaki; Tricia D Larsen; Angela L Wachal; Michelle D Schimelpfenig; Lucinda J Weaver; Samuel D R Dooyema; Eli J Louwagie; Michelle L Baack Journal: Am J Physiol Heart Circ Physiol Date: 2016-01-22 Impact factor: 4.733
Authors: W Todd Cade; Philip T Levy; Rachel A Tinius; Mehgna D Patel; Swati Choudhry; Mark R Holland; Gautam K Singh; Alison G Cahill Journal: Pediatr Res Date: 2017-06-28 Impact factor: 3.756
Authors: Rebecca M Reynolds; Keith M Allan; Edwin A Raja; Sohinee Bhattacharya; Geraldine McNeill; Philip C Hannaford; Nadeem Sarwar; Amanda J Lee; Siladitya Bhattacharya; Jane E Norman Journal: BMJ Date: 2013-08-13
Authors: Megan E Paulsen; Sarah Jane Brown; Katherine M Satrom; Johannah M Scheurer; Sara E Ramel; Raghavendra B Rao Journal: Neonatology Date: 2021-08-19 Impact factor: 5.106